Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
McKesson
Baxter
Merck
Medtronic

Last Updated: September 26, 2022

Details for New Drug Application (NDA): 211450


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 211450 describes CLOBETASOL PROPIONATE, which is a drug marketed by Aleor Dermaceuticals, Glenmark Pharms Ltd, Ingenus Pharms Llc, Padagis Israel, Taro, Amneal, Aurobindo Pharma Usa, Cosette, Encube, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Pai Holdings Pharm, Rising, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Padagis Us, Actavis Mid Atlantic, Akorn, Cadila, Novel Labs Inc, Taro Pharms, Macleods Pharms Ltd, Prinston Inc, Saptalis Pharms, Solaris Pharma Corp, Wockhardt Bio Ag, Apotex, and Ani Pharms, and is included in seventy-eight NDAs. It is available from forty-two suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 211450
Tradename:CLOBETASOL PROPIONATE
Applicant:Glenmark Pharms Ltd
Ingredient:clobetasol propionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 211450
Medical Subject Heading (MeSH) Categories for 211450
Suppliers and Packaging for NDA: 211450
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE clobetasol propionate AEROSOL, FOAM;TOPICAL 211450 ANDA Glenmark Pharmaceuticals Inc., USA 68462-625 68462-625-27 50 g in 1 CAN (68462-625-27)
CLOBETASOL PROPIONATE clobetasol propionate AEROSOL, FOAM;TOPICAL 211450 ANDA Glenmark Pharmaceuticals Inc., USA 68462-625 68462-625-94 100 g in 1 CAN (68462-625-94)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.05%
Approval Date:Sep 9, 2019TE:AB2RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Colorcon
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.